{"entity":{"type":"insider","cik":"0001612372","url":"/insider/0001612372","json_url":"/insider/0001612372.json","name":"Watson W. Mark","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":10,"n_filings":9,"first":"2014-09-09","last":"2026-05-26","span_basis":"filed_date"},"name_variants":[{"name":"Watson W. Mark","source":"filing","n_filings":9,"first_seen":"2014-09-09","last_seen":"2026-05-26"}],"transactions":[{"id":5777357,"accession":"0001437749-26-018385","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-26-018385","line_url":"/filing/0001437749-26-018385#line-1","is_derivative":false,"issuer_cik":"0000072444","issuer_name":"Vaxart, Inc.","issuer_ticker":"VXRT","issuer_name_source":null,"issuer_url":"/issuer/0000072444","owner_cik":"0001612372","owner_name":"Watson W. Mark","owner_url":"/insider/0001612372","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.653,"price_display":"0.65","price_state":"stated","total_value":6530.0,"total_display":"6,530.00","shares_owned_after":134125.0,"shares_owned_after_display":"134,125","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-22","filed_date":"2026-05-26","scope":"insider"},{"id":4286945,"accession":"0001437749-25-037051","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-25-037051","line_url":"/filing/0001437749-25-037051#line-2","is_derivative":false,"issuer_cik":"0000072444","issuer_name":"Vaxart, Inc.","issuer_ticker":"VXRT","issuer_name_source":null,"issuer_url":"/issuer/0000072444","owner_cik":"0001612372","owner_name":"Watson W. Mark","owner_url":"/insider/0001612372","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":0.41,"price_display":"0.41","price_state":"stated","total_value":6150.0,"total_display":"6,150.00","shares_owned_after":119125.0,"shares_owned_after_display":"119,125","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-17","filed_date":"2025-12-05","scope":"insider"},{"id":4286943,"accession":"0001437749-25-037051","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-25-037051","line_url":"/filing/0001437749-25-037051#line-1","is_derivative":false,"issuer_cik":"0000072444","issuer_name":"Vaxart, Inc.","issuer_ticker":"VXRT","issuer_name_source":null,"issuer_url":"/issuer/0000072444","owner_cik":"0001612372","owner_name":"Watson W. Mark","owner_url":"/insider/0001612372","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":0.407,"price_display":"0.41","price_state":"stated","total_value":2035.0,"total_display":"2,035.00","shares_owned_after":124125.0,"shares_owned_after_display":"124,125","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-17","filed_date":"2025-12-05","scope":"insider"},{"id":4863642,"accession":"0001437749-25-024250","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-25-024250","line_url":"/filing/0001437749-25-024250#line-1","is_derivative":false,"issuer_cik":"0000072444","issuer_name":"Vaxart, Inc.","issuer_ticker":"VXRT","issuer_name_source":null,"issuer_url":"/issuer/0000072444","owner_cik":"0001612372","owner_name":"Watson W. Mark","owner_url":"/insider/0001612372","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.405,"price_display":"0.40","price_state":"stated","total_value":4050.0,"total_display":"4,050.00","shares_owned_after":104125.0,"shares_owned_after_display":"104,125","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-29","filed_date":"2025-07-31","scope":"insider"},{"id":2758536,"accession":"0001437749-24-020694","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-24-020694","line_url":"/filing/0001437749-24-020694#line-1","is_derivative":false,"issuer_cik":"0000072444","issuer_name":"Vaxart, Inc.","issuer_ticker":"VXRT","issuer_name_source":null,"issuer_url":"/issuer/0000072444","owner_cik":"0001612372","owner_name":"Watson W. Mark","owner_url":"/insider/0001612372","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.6789,"price_display":"0.68","price_state":"stated","total_value":13578.0,"total_display":"13,578.00","shares_owned_after":78125.0,"shares_owned_after_display":"78,125","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-18","filed_date":"2024-06-20","scope":"insider"},{"id":6601413,"accession":"0001437749-22-029843","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-22-029843","line_url":"/filing/0001437749-22-029843#line-1","is_derivative":false,"issuer_cik":"0000072444","issuer_name":"Vaxart, Inc.","issuer_ticker":"VXRT","issuer_name_source":null,"issuer_url":"/issuer/0000072444","owner_cik":"0001612372","owner_name":"Watson W. Mark","owner_url":"/insider/0001612372","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.757,"price_display":"0.76","price_state":"stated","total_value":15140.0,"total_display":"15,140.00","shares_owned_after":20000.0,"shares_owned_after_display":"20,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-28","filed_date":"2022-12-28","scope":"insider"},{"id":2688973,"accession":"0001103021-20-000138","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001103021-20-000138","line_url":"/filing/0001103021-20-000138#line-1","is_derivative":false,"issuer_cik":"0001103021","issuer_name":"BIODELIVERY SCIENCES INTERNATIONAL INC","issuer_ticker":"BDSI","issuer_name_source":null,"issuer_url":"/issuer/0001103021","owner_cik":"0001612372","owner_name":"Watson W. Mark","owner_url":"/insider/0001612372","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13000.0,"shares_display":"13,000","price_per_share":5.18,"price_display":"5.18","price_state":"stated","total_value":67340.0,"total_display":"67,340.00","shares_owned_after":52979.0,"shares_owned_after_display":"52,979","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-17","filed_date":"2020-08-19","scope":"insider"},{"id":2427157,"accession":"0001127602-20-012135","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-20-012135","line_url":"/filing/0001127602-20-012135#line-1","is_derivative":false,"issuer_cik":"0001010612","issuer_name":"SYKES ENTERPRISES INC","issuer_ticker":"SYKE","issuer_name_source":null,"issuer_url":"/issuer/0001010612","owner_cik":"0001612372","owner_name":"Watson W. Mark","owner_url":"/insider/0001612372","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":26.1,"price_display":"26.10","price_state":"stated","total_value":78300.0,"total_display":"78,300.00","shares_owned_after":5991.0,"shares_owned_after_display":"5,991","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-30","filed_date":"2020-03-30","scope":"insider"},{"id":2455177,"accession":"0000899243-20-003818","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-003818","line_url":"/filing/0000899243-20-003818#line-1","is_derivative":false,"issuer_cik":"0001042418","issuer_name":"Inhibitor Therapeutics, Inc.","issuer_ticker":"INTI","issuer_name_source":null,"issuer_url":"/issuer/0001042418","owner_cik":"0001612372","owner_name":"Watson W. Mark","owner_url":"/insider/0001612372","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":0.0619,"price_display":"0.06","price_state":"stated","total_value":30.95,"total_display":"30.95","shares_owned_after":1054100.0,"shares_owned_after_display":"1,054,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-12","filed_date":"2020-02-10","scope":"insider"},{"id":6205014,"accession":"0001209191-14-057081","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-057081","line_url":"/filing/0001209191-14-057081#line-1","is_derivative":false,"issuer_cik":"0001042418","issuer_name":"HedgePath Pharmaceuticals, Inc.","issuer_ticker":"HPPI","issuer_name_source":null,"issuer_url":"/issuer/0001042418","owner_cik":"0001612372","owner_name":"Watson W. Mark","owner_url":"/insider/0001612372","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.13,"price_display":"0.13","price_state":"stated","total_value":1300.0,"total_display":"1,300.00","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-08","filed_date":"2014-09-09","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":10,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":8,"open_market":true},{"code":"S","label":"Open-market sale","n":2,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":10},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000072444","name":"Vaxart, Inc.","url":"/issuer/0000072444","role":"Director","n_filings":5,"first_seen":"2022-12-28","last_seen":"2026-05-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001103021","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","url":"/issuer/0001103021","role":"Director","n_filings":1,"first_seen":"2020-08-19","last_seen":"2020-08-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001010612","name":"SYKES ENTERPRISES INC","url":"/issuer/0001010612","role":"Director","n_filings":1,"first_seen":"2020-03-30","last_seen":"2020-03-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001042418","name":"Inhibitor Therapeutics, Inc.","url":"/issuer/0001042418","role":"Director","n_filings":2,"first_seen":"2014-09-09","last_seen":"2020-02-10"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001612372","retrieved_at":"2026-08-21T17:46:08+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}